Incidence of invasive aspergillosis in older patients with AML or high-risk MDS
REMISSION
The incidence of IA in this cohort was 21% and IA occurred mostly during remission induction chemotherapy. This is similar to findings in other studies described in a recent meta-analysis, although incidences of IA ranged from 3.2%-43.1% during remission induction chemotherapy in patients without prophylaxis [